THE LEADER OF NONINVASIVE FLUID STATUS & BODY MASS COMPOSITION
ImpediMed Ltd. is the world leader in the development and distribution of medical devices employing Bioimpedance Spectroscopy (BIS) technologies for use in the non-invasive clinical assessment and monitoring of fluid status. ImpediMedÕs primary product range consists of a number of medical devices that aid surgeons, oncologists, therapists and radiation oncologists in the clinical assessment of patients for the potential onset of secondary lymphoedema. Pre-operative clinical assessment in breast cancer survivors, before the onset of symptoms, may prevent the condition from becoming a lifelong management issue and thus improve the quality of life of the cancer survivor. ImpediMed had the first medical device with an FDA clearance in the United States to aid health care professionals in the clinical assessment of secondary lymphoedema of the arm in female breast cancer patients.
- Company Name:Impedimed
(View Trends)
-
Headquarters: (View Map)Brisbane, Australia
-
Medical Devices
-
50 - 200 employees
- 10465618 Global Rank
- 4131649 United States
-
Search100.00%
-
Direct0.00%
-
Display0.00%
-
Mail0.00%
-
Referrals0.00%
-
Social0.00%